Genmab A/S (GMAB)
35.45
+0.13
(+0.37%)
USD |
NASDAQ |
Sep 28, 15:01
Genmab Cash from Operations (Annual) : 1.190B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.190B |
| December 31, 2024 | 1.127B |
| December 31, 2023 | 1.071B |
| December 31, 2022 | 552.65M |
| December 31, 2021 | 354.10M |
| December 31, 2020 | 983.75M |
| December 31, 2019 | 198.78M |
| December 31, 2018 | 160.62M |
| December 31, 2017 | 240.94M |
| December 31, 2016 | 48.69M |
| December 31, 2015 | 46.30M |
| December 31, 2014 | 23.61M |
| December 31, 2013 | -22.79M |
| December 31, 2012 | 12.24M |
| Date | Value |
|---|---|
| December 31, 2011 | -81.61M |
| December 31, 2010 | 47.59M |
| December 31, 2009 | -106.86M |
| December 31, 2008 | -101.18M |
| December 31, 2007 | 93.60M |
| December 31, 2006 | -64.40M |
| December 31, 2005 | -34.70M |
| December 31, 2004 | -61.71M |
| December 31, 2003 | -46.43M |
| December 31, 2002 | -39.44M |
| December 31, 2001 | -14.79M |
| December 31, 2000 | -1.076M |
| December 31, 1999 | -1.354M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AbbVie, Inc. | 19.03B |
| Ascendis Pharma A/S | 60.83M |
| Zealand Pharma A/S | 987.74M |
| Bavarian Nordic A/S | 411.60M |
| Evaxion AS | -6.645M |